Penka Petrova, Chief Development Officer at Trillium Therapeutics Inc. (TRIL), sold 508 shares at $15.21 ($8K) on 2021-01-11, disclosed to the SEC on 2021-01-13.
Scheduled sale ($8k) by Chief Development Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| TRIL | SELL | 2021-02-10 | $142K | — | Filing → |
| TRIL | SELL | 2021-01-12 | $40K | — | Filing → |
| TRIL | SELL | 2021-01-11 | $40K | — | Filing → |